Associated Papers
Structural basis for recruitment of the CHK1 DNA damage kinase by the CLASPIN scaffold protein.
Day M et al.
Structure (london, England : 1993), 2021
Recurrent CDC25C mutations drive malignant transformation in FPD/AML.
Yoshimi A et al.
Nature Communications, 2014
ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres.
Thanasoula M et al.
The Embo Journal, 2012
Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.
Bagheri-Yarmand R et al.
Cancer Research, 2010
p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation.
Eymin B et al.
Cell Cycle (georgetown, Tex.), 2006
G2 checkpoint abrogators as anticancer drugs.
Kawabe T
Molecular Cancer Therapeutics, 2004
Functional analysis of C-TAK1 substrate binding and identification of PKP2 as a new C-TAK1 substrate.
Müller J et al.
The Embo Journal, 2003
Select a paper to view details